terlipressin acetate

terlipressin acetate (TERLIVAZ) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

TERLIVAZ is a marketed brand name for terlipressin acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

terlipressin acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.